Overview

Organoids are advanced 3D in vitro cell models that closely mimic the structure, microenvironment and function of human organs, acting as core cutting-edge tools for drug R&D and greatly enhancing the clinical relevance and translation efficiency of research data. We develop standardized, high-stability organoid models with rigorous construction and full-process quality control. Our models boast high structural fidelity, stable performance and excellent batch-to-batch consistency, making them ideal for high-throughput drug screening, efficacy testing and preclinical safety evaluation, and providing reliable in vivo-like experimental support for innovative drug development and clinical translation.
Overview
  • Ready-to-Use

    Ready-to-Use

    No differentiation or complex induction required. Ready for immediate use upon delivery, cutting culture time and resources.

  • Highly Biomimetic

    Highly Biomimetic

    Self-assembled 3D tissue with multiple native cell types to mimic physiological microenvironments.

  • Stable Functional Performance

    Stable Functional Performance

    Captures tissue-specific activities and phenotypic responses for reproducible toxicity testing.

  • Multidimensional QC

    Multidimensional QC

    Batch-consistent morphology, markers and function; well-controlled organoid size and structure.

Operating Videos

Product Categories

Our Services

  • Drug-Induced Cardiotoxicity Assessment Service

    Integrated human iPSC-derived cardiac organoids with MEA technology for reliable, real-time cardiotoxicity assessment in preclinical drug development.

    Learn More arrow-rightarrow-right
    Drug-Induced Cardiotoxicity Assessment Service

FAQ

  • Q

    How are the products shipped?

  • Q

    How should the products be handled upon receipt?

  • Q

    How is batch consistency ensured?

  • Q

    What applications and assays are supported?